13D Filing: Eses Holdings and Adamis Pharmaceuticals Corp (ADMP)

Exhibit No.

Description

99.1

Joint Filing Agreement, dated April 14, 2016, between Eses Holdings (FZE) and Ahmed Shayan Fazlur Rahman relating to the filing of a joint statement of Schedule 13D.

99.2

Common Stock Purchase Agreement (incorporated by reference to Exhibit No. 99.2 to the Schedule 13D filed with the SEC on November 22, 2010).

99.3

Registration Rights Agreement (incorporated by reference to Exhibit No. 99.3 to the Schedule 13D filed with the SEC on November 22, 2010).

99.4

First Amendment to Common Stock Purchase Agreement (incorporated by reference to Exhibit No. 99.4 to the Schedule 13D filed with the SEC on July 5, 2011).

99.5

Second Amendment to Common Stock Purchase Agreement (incorporated by reference to Exhibit No. 99.5 to the Schedule 13D filed with the SEC on November 21, 2011).

99.6

Third Amendment to Common Stock Purchase Agreement (incorporated by reference to Exhibit No. 99.6 to the Schedule 13D filed with the SEC on February 3, 2012).

13D Filing: Eses Holdings and Adamis Pharmaceuticals Corp (ADMP)

Published on April 18, 2016 at 9:38 am by Insider Monkey Staff in Hedge Funds

Page 8 of 9 – SEC Filing

Follow Dmk Pharmaceuticals Corp (NASDAQ:DMK)

Follow Dmk Pharmaceuticals Corp (NASDAQ:DMK)

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Published on October 30, 2024 at by Inan Dogan, PhD

A New Dawn is Coming to U.S. Stocks

Published on November 16, 2024 at by Insider Monkey Staff